Leonard R. Borrmann
Directeur Général chez Centricity Vision, Inc.
Profil
Leonard R.
Borrmann has been Executive Vice President-Research and Development of Advanced Medical Optics, Inc. since February 2007.
Previously, he was Corporate Vice President-Research and Development of Advanced Medical Optics from September 2006 to February 2007, Senior Vice President-Research and Development from July 2005 to September 2006 and Vice President-Surgical Research and Business Development from March 2004 to June 2005.
Dr. Borrmann was President and Chief Executive Officer of Insert Therapeutics, Inc. from August 2002 to February 2004 and President, Chief Executive Officer and a Director of Maret Pharmaceuticals, Inc. from December 2000 to March 2002.
He was Chief Executive Officer of ACADIA Pharmaceuticals, Inc. from May 1998 to September 2000.
From June 1984 to May 1998, Dr. Borrmann held various clinical and business development positions at Allergan, Inc., including Vice President of Business Development from June 1992 to May 1998.
He holds a PhD degree.
Postes actifs de Leonard R. Borrmann
| Sociétés | Poste | Début |
|---|---|---|
| Centricity Vision, Inc. | Directeur Général | 20/12/2023 |
Anciens postes connus de Leonard R. Borrmann
| Sociétés | Poste | Fin |
|---|---|---|
Advanced Medical Optics, Inc.
 Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Directeur Technique/Scientifique/R&D | 27/02/2009 |
Insert Therapeutics, Inc.
 Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | President | 01/02/2004 |
Maret Pharmaceuticals, Inc.
 Maret Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Maret Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of hematology and oncology disorders. The company is based in Newport Beach, CA. Maret Pharmaceuticals was acquired by Essential Therapeutics, Inc. on March 12, 2002 for $6.72 million. | President | 01/03/2002 |
| ACADIA PHARMACEUTICALS INC. | President | 01/09/2000 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/05/1998 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Advanced Medical Optics, Inc.
Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Health Technology |
Insert Therapeutics, Inc.
Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Commercial Services |
Maret Pharmaceuticals, Inc.
Maret Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Maret Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of hematology and oncology disorders. The company is based in Newport Beach, CA. Maret Pharmaceuticals was acquired by Essential Therapeutics, Inc. on March 12, 2002 for $6.72 million. | Commercial Services |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Centricity Vision, Inc. |
